PM
MTCR

Prosight Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Prosight Management’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,145,034
Closed -$3.93M – 56
2021
Q3 		$3.93M Buy
1,145,034
+275,952
+32% +$861K 2.16% 16
2021
Q2 		$3.3M Buy
869,082
+564,597
+185% +$2.33M 2.07% 20
2021
Q1 		$1.89M Sell
304,485
-258,818
-46% -$2.29M 1.55% 22
2020
Q4 		$4.43M Buy
563,303
+44,507
+9% +$408K 2.05% 19
2020
Q3 		$5.3M Buy
+518,796
New +$5.31M 2.52% 17

Other funds holding MTCR

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prosight Management's MTCR Position: Q4 2021 in Review

Prosight Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q4 2021, closing a stake of 1,145,034 shares — an estimated $3.93M sold.

Prosight Management first reported a position in MTCR in Q3 2020 and held it in 5 quarters. The position peaked at $5.3M in Q3 2020. 31 funds tracked by Wall St. Rank hold MTCR as of Q4 2021.

  • Prosight Management reported no remaining Metacrine, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Prosight Management sold 1,145,034 Metacrine, Inc. Common Stock shares in Q4 2021, an estimated $3.93M.
  • Prosight Management first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Prosight Management's Metacrine, Inc. Common Stock position peaked at $5.3M in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q4 2021.

Based on Prosight Management's 13F filing for Q4 2021, filed 14 Feb 2022.